Developed with input from federal regulators, AABB’s regulatory resources are clear, user-friendly tools that help blood centers and transfusion services protect donor and patient safety at each step in the transfusion chain.
Reporting Fatalities Related to Blood Transfusion and Donation to FDA
REGULATORY UPDATE: AABB Seeks Volunteers for DHQ v2.1 Implementation Focus Groups
January 26, 2021
January 25, 2021
Janet Woodcock Named Acting FDA Commissioner
January 21, 2021